| 摘要 |
Steroids having a 15,16-double bond, especially gestodene (17 alpha -ethynyl-17 beta -hydroxy-18-methyl-4,15-estradien-3-one), can be used for the treatment of carcinomas that can be inhibited in their growth by the protein TGF beta (Tumor Growth Factor beta ), especially breast carcinoma. At least one antiestrogen can be coadministered. |
